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Abstract 
Purpose: Charcot Marie Tooth disease (CMT) describes a group of hereditary neuropathies that 
present with distal weakness, wasting and sensory loss. Small studies indicate that people with 
CMT have reduced daily activity levels. This raises concerns as physical inactivity increases the 
risk of a range of co- morbidities, an important consideration in the long-term management of 
this disease. This study aimed to compare physical activity, patterns of sedentary behaviour and 
overall energy expenditure of people with CMT and healthy matched controls.  
Methods: We compared 20 people with CMT and 20 matched controls in a comparison of 
physical activity measurement over seven days, using an activity monitor. Patterns of sedentary 
behaviour were explored through a power law analysis. 
Results: Results showed a decrease in daily steps taken in the CMT group, but somewhat 
paradoxically, they demonstrate shorter bouts of sedentary activity and more frequent 
transitions from sedentary to active behaviours. No differences were seen in energy expenditure 
or time spent in sedentary, moderate or vigorous activity.  
Conclusion: The discrepancy between energy expenditure and number of steps could be due to 
higher energy requirements for walking, but also may be due to an over-estimation of energy 
expenditure by the activity monitor in the presence of muscle wasting. Alternatively, this finding 
may indicate that people with CMT engage more in activities or movement not related to 
walking.  
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Implications for Rehabilitation 
 
 People with Charcot-Marie-Tooth disease did not show a difference in energy 
expenditure over seven days compared to healthy controls, but this may be due to 
higher energy costs of walking, and/or an over estimation of energy expenditure by the 
activity monitor in a population where there is muscle wasting.  This needs to be 
considered when interpreting activity monitor data in people with neuromuscular 
diseases.  
 Compared to healthy controls, people with Charcot-Marie-Tooth disease had a lower 
step count over seven days, but exhibited more frequent transitions from sedentary to 
active behaviours 
 High Body Mass Index and increased time spent sedentary were related factors that 
have implications for general health status.  
 Understanding the profile of physical activity and behaviour can allow targeting of 
rehabilitation interventions to address mobility and fitness. 
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Introduction 
Charcot Marie Tooth disease (CMT) describes a group of hereditary neuropathies that present 
with distal weakness, wasting and sensory loss. These symptoms impact on physical activity [1]  
and functions such as walking  [2] . The primary impairments lead to altered gait patterns, 
requiring compensatory strategies to achieve functional mobility [3] . It has been shown that 
walking is more effortful for people with CMT [4] [5] and this could contribute to reductions in 
physical activity.  
Physical inactivity is implicated as a risk factor for developing a range of morbidities including 
obesity, cardiovascular disease, stroke, type-2 diabetes and osteoporosis [6]. Most forms of 
CMT do not alter life expectancy, so the prevention of co-morbidities is an important 
consideration in the long-term management of this disease [7] .  
Small studies indicate that people with CMT have reduced daily activity levels. Accelerometers 
were used to quantify activities of daily living for eight people with CMT1A and eight matched 
controls over 24 hours [7] . No difference in step count was observed between the groups, but 
there were lower counts for stair climbing and sit to stand transitions. Knee extensor strength 
correlated positively with both activities. The aerobic capacity of people with CMT is reduced, 
with V02 max during exercise testing lower than normal values [8] [9]. This is an indicator of 
cardiovascular de-conditioning secondary to reduced physical activity. 
The reasons for inactivity have had some exploration. A recent study used a mixed methods 
approach to explore facilitators and barriers to physical activity [10] using the Physical Activity 
Disability Survey. In addition, open ended questions were asked to identify barriers and 
facilitators in 44 people with CMT. The most active people tended to be younger, have greater 
self-efficacy, lower fatigue and greater balance confidence. Self-efficacy for physical activity and 
fatigue predicted 31% of the variance in physical activity on regression modelling. Key barriers 
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related to impairments of physical functioning, including poor balance, muscle weakness and 
pain.   
Study purpose: It is suggested that optimising physical activity should be part of a multi-factorial 
approach to improve societal participation in people with neuromuscular disease [11] . In order 
to embark on this, there must be a greater understanding of the patterns of activity observed in 
people with CMT. This study aimed to compare physical activity, patterns of sedentary 
behaviour and overall energy expenditure of people with CMT and healthy matched 
controls.  
Materials and Methods 
Subjects: Twenty individuals with CMT were recruited from genetic peripheral neuropathy clinics 
at the National Hospital for Neurology and Neurosurgery (NHNN) as part of another trial of a 
home exercise intervention [12]. Physical activity data collection took place during the control 
phase of the exercise trial, where participants were asked to continue with their normal routine 
and activities. Participants were included if they were aged 18-70 years, had a clinical diagnosis 
of CMT, or related condition, and were able to walk 50 metres with or without an aid. 
Participants were excluded if they had another significant neurological disorder, major co-
morbidities, severe congenital hip dysplasia, or had undergone lower limb surgery in the six 
months prior to recruitment.  
 
Data for twenty healthy control participants was extracted from a normative database, held at 
the MRC Muscle Performance and Training Laboratory (Movelab), Newcastle-upon-Tyne, and 
were matched for age and sex. Subjects included in the database were recruited from the Inland 
Revenue, Newcastle Council, Newcastle University employees and from an advert on a 
website. They were included if they had the ability to undertake physical activity monitoring for 7 
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days, were aged 18-70 years, had no heart complaints, or any other conditions that may affect 
day-to-day activity such as diabetes, chronic pain, heart, liver or neuromuscular disease.  
 
All participants gave written informed consent, and a local research ethics committee gave the 
study approval before data collection began.  
 
Physical activity measures: Physical activity was objectively measured using the SenseWear 
activity monitor (SenseWear Pro3, Bodymedia Inc, PA, USA), which is a validated multi-sensor 
device that incorporates skin temperature, galvanic skin response and bi-axial accelerometry 
with demographic information such as age, sex and body mass index (BMI) [13] . From this, the 
SenseWear activity monitor derives measures of physical activity and energy expenditure. The 
SenseWear activity monitor’s output is represented as calorie expenditure (Kcal), energy 
expenditure (METs; 1 MET is a person’s resting metabolic activity: 1 Kcal·kg-1· h-1), steps taken, 
as well as time spent in sedentary (<3 METs), moderate (3-6 METs) and vigorous activities (≥6 
METs). The SenseWear activity monitor has been shown to correlate strongly (r=0.85, P<0.001) 
with indirect calorimetry when measuring energy expenditure in healthy people and chronic 
respiratory diseases, but it may underestimate step count at high walking speeds [14] [15] [16] . 
The SenseWear armband was placed in direct contact with the skin, over the triceps muscle of 
the right arm. The monitor was worn for seven days during waking hours but removed if there 
was to be contact with water.  
 
Clinical measures: Control participants and people with CMT underwent height and weight 
measurement by physiotherapists at the MRC Muscle Performance and Training Laboratory 
and NHNN respectively. BMI was calculated from this data.  
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People with CMT underwent additional assessments, including a full medical history, physical 
status, gait performance and self-reported measures. Disease severity was scored by a 
neurologist using the CMT Examination Score [17] . Lower limb muscle strength was evaluated 
using the CITEC hand held dynamometer (C.I.T.Technics, Netherlands). The following muscle 
groups were tested: hip extensors, hip abductors, hip adductors, hip flexors, knee extensors, 
knee flexors, plantarflexors, dorsiflexors. Walking endurance was measured using the six 
minute walk test [18] . Self-reported fatigue, walking ability and reported activity levels were 
measured in people with CMT using the Fatigue Severity Scale (FSS), Walk-12 and Phone-
FITT questionnaires respectively [19] [20] .  
 
Analysis: Each control participant’s SenseWear results were synchronized, by time period worn, 
to their matched subject with CMT. Hence, between group results were compared for the same 
time periods. Variables were averaged across the seven day period of wear. The following 
measures were recorded using the SenseWear activity monitor in both groups, and are 
expressed as an individual’s average day: calorie expenditure (Kcals); energy expenditure 
(METs); step count; minutes spent performing sedentary activities(<3 METs); minutes spent in 
moderately vigorous activities (3-6 METs); minutes spent in vigorous activities (≥6 METs). 
 
A further analysis of sedentary behaviour patterns was performed, by a method used to 
evaluate activity in people with mitochondrial disease [21] [22] . Data from the SenseWear 
activity monitor was used for a power law analysis. The density of bouts of sedentary behaviour, 
for a specific time bin width, was plotted against the length of the bout on a logarithmic scale to 
calculate power distribution. Lorentz curves were calculated from the power distributions as a 
fraction of the total sedentary time that is accumulated in bouts longer than any sedentary 
period of length. 
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Pairs of curves for patient and control groups were then plotted as the fraction of sedentary 
time/density of sedentary bouts. In addition, the patterns of activity were explored through 
identifying transitions from inactive to active behaviour. These sedentary to active transitions 
were normalised to the length of the recorded activity. 
Unpaired two-tailed t-tests were performed to explore differences in activity variables and BMI 
between people with CMT and control participants. A secondary analysis using linear regression 
was used to explore predictors of activity variables, measured by the SenseWear activity 
monitor, from the clinical measures. All analyses were performed using STATA statistical 
software, version 13. All values are expressed as mean ± standard deviation (SD) unless 
otherwise stated. 
Results:  
Group Differences: Twenty people with CMT (table 1) and 20 healthy matched controls were 
compared in this study (table 2). Seven of the people with CMT wore ankle foot orthoses 
(AFOs) and one of those people also used an elbow crutch unilaterally. The CMT group were 
heterogeneous and their diagnoses and presentation are outlined in table 1.  No difference was 
seen in age and BMI between groups. 
There were no significant group differences between calorie expenditure, energy expenditure 
(METs), or time in sedentary, moderate or vigorous activities (table 2). However, as shown in 
figure 1a, people with CMT took significantly fewer steps each day than the control group 
(difference between groups: -4403.25 steps, P<0.00001, 95% Confidence Intervals CI: -6144.25   
-2662.25). 
For the power law analysis, some errors in raw data export led to some missing data. Six 
records were lost from the CMT group and two from the control group. The remaining data was 
analysed and showed that transitions from being sedentary to active, relative to daily activity, 
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were significantly higher in patients with CMT compared with controls (figure 1b, mean 
difference 5.54; 95% CI: 3.23 to 7.86; p <0.001). Sedentary time in people with CMT tends to be 
made up of shorter bouts of sedentary activity compared to controls (figure 2) 
Predictors of physical activity for people with CMT: Linear regression showed significant 
predictors of some of the physical activity variables: calorie expenditure, METs, time spent 
sedentary and in moderate activity (table 3). No predictors from the data collected in this study 
were identified for step count, time spent in vigorous activity or sedentary to active transitions. 
Calorie expenditure had significant positive relationships with the Walk-12 score and hip 
abductor strength; METs related negatively to BMI; sedentary time related positively to BMI; 
time spent in moderate activity related to disease severity (CMTES), the walk-12 score and hip 
abductor strength (table 3).   
 
Discussion 
The results of this study indicate a number of paradoxical findings. People with CMT expend the 
same amount of energy (calories and METs) as the matched controls, but take fewer steps per 
day. An earlier study of activity monitoring [7]  found no difference in step count, but this was 
only for eight people monitored over 24 hours. There will be a greater risk of bias due to the 
short duration and a small sample of a heterogeneous group. There is a suggestion, however, 
that greater effort and energy is expended when people with CMT walk [4] [5] . It is possible that 
this could account for the higher levels of energy expenditure, if we assume that walking is the 
main mode of activity. This is difficult to verify, however, plus there were no differences in the 
time spent in moderate activity. 
 An alternative explanation is that the algorithms used to calculate energy expenditure rely on 
anthropomorphic assumptions according to normal body composition. There is an estimation of 
 10 
 
the amount of muscle tissue, which is key to energy generation. People with CMT have 
significant levels of muscle wasting so there may be an over-estimation of energy expenditure. It 
is possible that they do expend less energy but the SenseWear activity monitor is not yet 
validated in people with CMT. That would require comparison with indirect calorimetry or doubly 
labelled water measurements to explore and quantify the shortfall.  
The second paradoxical finding is that people with CMT have shorter bouts of sedentary activity 
and make more transitions from sedentary to active behaviours. This is despite fewer steps per 
day. This may be an indication that people with CMT move in other ways than just accumulating 
steps when walking, for example time spent in standing, however it is generally reported that 
people with CMT are a less physically active group. Frequent falls and poor balance are 
commonly reported problems and could be associated with limited walking [22]. People with 
CMT may break up sedentary periods with more frequent transitions into standing, without 
accumulating a larger number of steps, however this would require more detailed exploration 
with accelerometers that can distinguish between lying, sitting and standing. The sample for this 
study was taken from participants who volunteered for a trial of exercise training. It is possible 
that this was a more motivated and active group than the general CMT population in that they 
put themselves forward for the main study. This analysis would need repeating on another 
sample of people with CMT without the participation bias in order to see if this finding re-occurs.  
The secondary analysis sought to observe whether clinical measures could predict levels of 
physical activity in the CMT sample. A higher BMI predicted lower MET expenditure and greater 
time spent sedentary. It is difficult to know at present which factor may have come first. Larger 
people may move less and be more sedentary, but it could also be these behaviours that 
contribute to higher BMI. If BMI is addressed through non exercise interventions, it would be 
interesting to see if changes in physical activity follow suit.  
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People with stronger hip abductor muscles expended more energy and spent more time in 
moderate activities. People with greater proximal strength will be less severely affected by CMT, 
so may find it easier to move more often. The CMTES measure of disease severity supports this 
in the prediction of moderate activity levels. A larger sample may demonstrate additional 
relationships with other muscle groups and may also reveal predictors of higher functioning 
individuals, of which there were few in this study.  
Self-reported walking ability, measured by the walk-12 score, predicted greater calorie 
expenditure and time spent in moderate activity. This may indicate that the people who are 
more moderately active perceive a better ability to mobilise in general. There were no 
relationships identified for step count, vigorous activity levels and sedentary to active transitions. 
This may have been due to the relatively small sample, but it could also be due to the limited 
parameters measured. Exploration of barriers to physical activity for people with CMT found that 
self-efficacy and balance confidence were significant factors [10].  These factors were not 
explored in this presented work and may have accounted for these variables. In particular, 
identifying the predictor of step count would have value in guiding targeting of physical activity 
interventions to improve overall mobility. 
The sample for this study were heterogeneous genetically (table 1), which introduces variability 
into the sample, but common patterns of impairment were noted. There were insufficient 
numbers in the rarer genetic groups to make meaningful comparisons, but the general 
presentation of distal muscle weakness was consistent in this sample.  
 
Conclusion: 
Physical activity monitoring of 20 people with CMT and 20 matched controls revealed that 
significantly fewer steps are taken by the CMT group, though clinical predictors were not 
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identified. Paradoxically, the participants with CMT took shorter sedentary bouts and had more 
sedentary to active transitions than the control group that may have been non-walking activity. 
There may have been a selection bias in this group as they volunteered for a study of exercise. 
Further work needs to be done to validate the use of activity monitors in key activities due to 
assumptions that may not account for muscle wasting. In addition, a greater range of clinical 
measures need to be used to explore predictions of activity behaviours.  
Acknowledgements: 
This work was funded by a research grant from the Muscular Dystrophy Campaign (RA2/782/1). 
MMR is grateful to the Medical Research Council (MRC), MRC Centre grant (G0601943), and 
the National Institutes of Neurological Diseases and Stroke and office of Rare Diseases 
(U54NS065712) for their support. This research was also supported by the National Institute for 
Health Research University College London Hospitals Biomedical Research Centre. 
Declarations of interest: The authors report no declarations of interest. 
  
 13 
 
References 
[1] Kalkman JS, Schillings ML, Zwarts MJ, van Engelen BGM, Bleijenberg G. The 
development of a model of fatigue in neuromuscular disorders: a longitudinal study. J 
Psychosom Res 2007;62:571–9.  
[2] Newman CJ, Walsh M, O’Sullivan R, Jenkinson A, Bennett D, Lynch B, et al. The 
characteristics of gait in Charcot-Marie-Tooth disease types I and II. Gait Posture 2007;26:120–
7.  
[3] Don R, Serrao M, Vinci P, Ranavolo A, Cacchio A, Ioppolo F, et al. Foot drop and 
plantar flexion failure determine different gait strategies in Charcot-Marie-Tooth patients. Clin 
Biomech Bristol Avon 2007;22:905–16. doi:10.1016/j.clinbiomech.2007.06.002. 
[4] Menotti F, Felici F, Damiani A, Mangiola F, Vannicelli R, Macaluso A. Charcot-Marie-
Tooth 1A patients with low level of impairment have a higher energy cost of walking than 
healthy individuals. Neuromuscul Disord NMD 2011;21:52–7. doi:10.1016/j.nmd.2010.09.008. 
[5] Ramdharry GM, Day BL, Reilly MM, Marsden JF. Hip flexor fatigue limits walking in 
Charcot-Marie-Tooth disease. Muscle Nerve 2009;40:103–11.  
[6] Everybody active, every day: a framework to embed physical activity into daily life - 
Publications - GOV.UK Available from: https://www.gov.uk/government/publications/everybody-
active-every-day-a-framework-to-embed-physical-activity-into-daily-life. Accessed 2015 Dec 14. 
[7] Menotti F, Laudani L, Damiani A, Macaluso A. Amount and intensity of daily living 
activities in Charcot–Marie–Tooth 1A patients. Brain Behav 2014;4:14–20.  
[8] Carter GT, Abresch RT, Fowler WM Jr, Johnson ER, Kilmer DD, McDonald CM. Profiles 
of neuromuscular diseases. Hereditary motor and sensory neuropathy, types I and II. Am J 
Phys Med Rehabil Assoc Acad Physiatr 1995;74:S140–9. 
 14 
 
[9] Wallace A, Dewar L, Sterr A, Hanna M, Trenell M, Pietrusz A, et al. Normative aerobic 
exercise values in CMT. Neuromuscul Disord 2015;25:S285–6.  
[10] Anens E, Emtner M, Hellström K. An exploratory study of physical activity in persons 
with Charcot-Marie-Tooth disease. Arch Phys Med Rehabil 2015 ;96(2):260-8  
[11] Voet NBM, Bleijenberg G, Padberg GW, van Engelen BGM, Geurts ACH. Effect of 
aerobic exercise training and cognitive behavioural therapy on reduction of chronic fatigue in 
patients with facioscapulohumeral dystrophy: protocol of the FACTS-2-FSHD trial. BMC Neurol 
2010;10:56.  
[12] Ramdharry GM, Pollard A, Anderson C, Laurá M, Murphy SM, Dudziec M, et al. A pilot 
study of proximal strength training in Charcot-Marie-Tooth disease. J Peripher Nerv Syst JPNS 
2014;19:328–32.  
[13] St-Onge M, Mignault D, Allison DB, Rabasa-Lhoret R. Evaluation of a portable device to 
measure daily energy expenditure in free-living adults. Am J Clin Nutr 2007;85:742–9. 
[14] Moore SA, Hallsworth K, Bluck LJC, Ford GA, Rochester L, Trenell MI. Measuring 
Energy Expenditure After Stroke Validation of a Portable Device. Stroke 2012;43:1660–2.  
[15] Dwyer TJ, Alison JA, McKeough ZJ, Elkins MR, Bye PTP. Evaluation of the SenseWear 
activity monitor during exercise in cystic fibrosis and in health. Respir Med 2009;103:1511–7.  
[16] Furlanetto KC, Bisca GW, Oldemberg N, Sant’anna TJ, Morakami FK, Camillo CA, et al. 
Step counting and energy expenditure estimation in patients with chronic obstructive pulmonary 
disease and healthy elderly: accuracy of 2 motion sensors. Arch Phys Med Rehabil 
2010;91:261–7.  
 15 
 
[17] Shy ME, Blake J, Krajewski K, Fuerst DR, Laura M, Hahn AF, et al. Reliability and 
validity of the CMT neuropathy score as a measure of disability. Neurology 2005;64:1209–14.  
[18] Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. 
Am J Respir Crit Care Med 1998;158:1384–7. 
[19] Gill DP, Jones GR, Zou GY, Speechley M. The Phone-FITT: a brief physical activity 
interview for older adults. J Aging Phys Act 2008;16:292–315. 
[20] Graham RC, Hughes RAC. Clinimetric properties of a walking scale in peripheral 
neuropathy. J Neurol Neurosurg Psychiatry 2006;77:977–9.  
[21] Apabhai S, Gorman GS, Sutton L, Elson JL, Plötz T, Turnbull DM, et al. Habitual 
physical activity in mitochondrial disease. PloS One 2011;6:e22294.  
[22] Chastin SFM, Granat MH. Methods for objective measure, quantification and analysis of 
sedentary behaviour and inactivity. Gait Posture 2010;31:82–6.  
[22]  Ramdharry GM, Entwistle L, Reilly MM. Frequency and circumstances of falls for adults   
        with Charcot Marie Tooth diseases. Neuromuscular Disorders 2011; 21: S18. 
 
  
 16 
 
Type of CMT Number of 
participants 
CMTES 
(median 
score) 
FSS 
(median 
score) 
Walk-12 
(median 
score) 
6MTW 
(m)  
Hip Ext 
MVC 
(N/Kg) 
Hip Flex 
MVC 
(N/Kg) 
Hip Abd 
MVC 
(N/Kg) 
Hip Add 
MVC 
(N/Kg) 
Knee 
Ext MVC 
(N/Kg) 
Knee 
Flex 
MVC 
(N/Kg) 
PF MVC 
(N/Kg) 
DF MVC 
(N/Kg) 
CMT type 1A 11 (10 
genetically 
confirmed 
PMP22 
duplication) 
10 30 38 357 ±70 3.2 ±0.8 2.6 ±0.8 2.3 ±1.2 1.9 ±0.8 3.5 ±1.5 1.8 ±0.9 3.6 ±1.6 1.1 ±1.0 
CMT type 2 5 (1 MPZ 
mutation, 1 
MFN2 
mutation, 3 
clinical 
diagnoses) 
10 20 39 350 ±45 3.3 ±0.4 2.7 ±0.5 1.9 ±0.5 2.7 ±1.0 5.0 ±0.6 2.1 ±0.6 3.6 ±2.4 0.9 ±1.0 
Intermediate 
CMT 
2 (clinical 
diagnoses) 11.5 26 33 331 ±81 4.0 ±2.0 2.9 ±1.9 2.8 ±1.9 2.3 ±1.0 3.5 ±3.5 2.3 ±2.1 3.1 ±3.8 0.6 ±0.3 
CMTX 1 (genetically 
confirmed 
Cx32 
mutation) 
10 47 40 322 3.4 2.2 1.7 1.8 4.4 1.3 4.6 1.2 
Hereditary 
sensory 
neuropathy 
type 1 
1 (SPTLC1 
mutation) 
14 30 35 360 3.1 2.3 1.9 1.9 4.6 2.1 2.7 0.1 
Overall  20 10 30 38.5 351 ±59 3.3 ±0.8 2.7 ±0.8 2.2 ±1.0 2.1 ±0.8 4.0 ±1.6 1.9 ±0.9 3.5 ±1.8 1.0 ±0.9 
Table 1: Diagnosis of study participants with CMT. PMP22: Peripheral Myelin Protein 22 gene; MPZ: myelin protein zero gene; MFN2: mitofusin 2 
gene; Cx32: Connexin 32 gene; SPTLC1: serine palmitoyltransferase, long chain base subunit 1 gene. CMTES: CMT Examination Score; FSS: 
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Fatigue Severity Score; MVC: Maximum voluntary contraction; Ext: extensor; Flex: flexor; Abd: abductor; Add: adductor; PF: plantar flexor; DF: 
dorsiflexor. Values are mean ± standard deviation, unless specified as median. 
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 Variable People with CMT Controls 
Demographics Age (years) 46 ± 15 46 ± 15 
 Sex 12 men, 8 women 12 men, 8 women 
 Body mass index (Kg/m2) 24.5 ± 3.4 24.7 ± 3.4 
Activity variables Calories per day 1916 ± 366.4 1946 ± 451.7 
 Average Mets  
(kcal·kg-1· h-1) 
1.86 ± 0.4 1.86 ± 0.4 
 Sedentary time  
(mins) per day 
720.1 ± 111.2 718.5 ± 115.6 
 Moderately active time (mins) 
per day 
133.0 ± 76.6 140.0 ± 94.1 
 Vigorously active time (mins) 
per day 
7.4 ± 10.1 6.6 ± 7.4 
 Number of steps per day 6814.3 ± 2587.0 * 11217.6 ± 2846.0 * 
Table 2: Comparison of the demographics and activity variables for CMT and control 
participants. * P<0.0001, no significant difference observed in other measures. 
 
Variable Regression outcome P value 
Calorie expenditure (Kcal) Walk-12 score:               R2 =0.26, a =1185, b =20 
Hip abductor MVC:        R2 =0.3, a =1471, b =200 
0.021 
0.012 
 
METs BMI:                                  R2 =0.25, a =3.3, b =-0.06 
 
0.026 
 
Steps per day No significant predictors - 
Sedentary time (mins) BMI:                                 R2 =0.25, a =312, b =16.7 0.024 
Moderate activity (mins) CMTES score:                 R2 =0.21, a =32.9, b =9.61 
Hip abductor MVC:        R2 =0.48, a =15.7, b =52.9 
Walk-12 score:               R2 =0.22, a =-7.02, b =3.86 
 
0.043 
0.001 
0.037 
Vigorous activity (mins) No significant predictors - 
Sedentary to active transitions No significant predictors - 
Table 3: Summary of significant predictors of physical activity parameters following linear regression 
analysis. MVC: maximum voluntary contraction (Newtons); a =intercept constant, b =slope coefficient  
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Figure 1: A-Box plot of mean (± standard deviation) average daily step rate over seven days for 20 
people with CMT and 20 matched controls. The difference in means was significant, P<0.0001. B- Box 
plot of mean (± standard deviation) sedentary to active transitions for 14 people with CMT and 18 
matched controls. The difference in means was significant, P<0.001. 
 
 
Figure 2: Power law analyses of the lengths of sedentary bouts of patients 14 people with CMT [dashed 
line] and 18 controls [solid line]. The sample of people with CMT had shorter bouts of sedentary time 
within the total sedentary time compared to controls.  
